GLOBUS MEDICAL INC (GMED) Stock Price
GMEDStock
$76.71+30.97%52W
Market Cap$10.30B
P/E19.15x
PEG Ratio1.49
Div yield—
Beta0.97
GMED Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-29.11%
Price vs S&P 500 (4W)4.58%
PEG Ratio1.49
VGM Score69.62
P/E Ratio (Annual)19.15x
GMED Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.10 | $1.34 | +21.91%(+$0.24) | |
| Q1 2026 | $0.92 | $1.12 | +21.73%(+$0.20) | |
| Q4 2025 | $1.15 | $1.28 | +10.96%(+$0.13) | |
| Q3 2025 | $0.78 | $1.18 | +51.14%(+$0.40) | |
| Q2 2025 | $0.75 | $0.86 | +14.92%(+$0.11) |
GMED Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.90
3.90
3.87
3.87
Industry Peers — Surgical & Medical Instruments(142)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
GMEDGLOBUS MEDICAL INC | B | B | B | 3.3x | 30.1% | 68.5% | 20.6% | $76.71 |
| SYKStryker Corporation | C | B | C | 4.4x | 11.8% | 65.3% | 21.3% | $294.66 |
| MMM3M Company | C | D | B | 3.4x | -5.0% | 39.4% | 18.4% | $164.75 |
| BSXBoston Scientific Corp. | C | B | C | 3.1x | 15.2% | 69.5% | 19.8% | $44.39 |
| BDXBecton, Dickinson and Co. | B | D | A | 2.5x | 6.3% | 46.7% | 9.6% | $191.75 |
| MDLNMedline Inc. Class A common stock | C | D | C | 1.6x | — | 26.2% | 6.0% | $35.96 |
| RMDResMed Inc. | C | C | B | 5.9x | 12.1% | 61.1% | 33.4% | $238.97 |
| DXCMDexCom, Inc. | C | B | B | 6.5x | 19.3% | 64.3% | 22.9% | $86.04 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | 8.5x | 7.4% | 36.8% | 20.4% | $384.02 |
| SOLVSolventum Corporation | C | C | B | 1.8x | — | 54.8% | 23.9% | $85.81 |
| BAXBaxter International Inc. | B | D | B | 1.1x | -0.8% | 30.7% | -2.3% | $25.28 |
About GLOBUS MEDICAL INC
Globus Medical Inc develops and manufactures medical devices for surgical procedures, with a primary focus on musculoskeletal solutions for spinal and orthopedic surgery. The company serves hospitals, physicians, and surgical centers through two business segments: musculoskeletal surgical devices and enabling surgical technologies. The majority of revenue comes from musculoskeletal products, with over half generated in the United States and the remainder from international operations.